Growth Metrics

Ocugen (OCGN) Revenue (2014 - 2026)

Ocugen posted quarterly Revenue of $1.5 million for Q1 2026, up 3.51% year-on-year from $1.5 million in Q1 2025, and up 894.3% on a QoQ basis from -$193000.0 in Q4 2025.

Ocugen (OCGN) has 7 years of Revenue data on file, last reported at $1.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 3.51% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 1.26% YoY), and the FY2025 full-year result was $4.4 million, up 8.83% from the prior year.
  • Revenue for Q1 2026 stood at $1.5 million, up from -$193000.0 in the prior quarter.
  • Across five years, Revenue topped out at $3.7 million in Q3 2023 and bottomed at -$193000.0 in Q4 2025.
  • The 5-year median for Revenue is $1.0 million (2024), against an average of $1.1 million.
  • The widest annual swing landed in 2023, when Revenue surged 693.78%; it then slumped 125.26% in 2025.
  • A 5-year view of Revenue shows it stood at $879000.0 in 2022, then jumped by 60.3% to $1.4 million in 2023, then tumbled by 45.78% to $764000.0 in 2024, then plunged by 125.26% to -$193000.0 in 2025, then surged by 894.3% to $1.5 million in 2026.
  • The last three Revenue figures came in at $1.5 million (Q1 2026), -$193000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.17 Bn
10 Ocugen 452.01 Mn 452.01 Mn - 1.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.53 Mn
Dec 31, 2025 -193,000.00
Sep 30, 2025 1.75 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 764,000.00
Sep 30, 2024 1.14 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.41 Mn
Sep 30, 2023 3.70 Mn
Jun 30, 2023 485,000.00
Mar 31, 2023 443,000.00
Dec 31, 2022 879,000.00
Sep 30, 2022 466,000.00
Jun 30, 2022 643,000.00
Mar 31, 2022 500,000.00
Jun 30, 2020 43,000.00
Sep 30, 2014 650.00 Mn